Cytokine Plasma Levels in Breast Cancer Patients, Before and After Surgery

J Interferon Cytokine Res. 2024 Mar;44(3):135-142. doi: 10.1089/jir.2023.0157. Epub 2024 Feb 20.

Abstract

Studying the levels of cytokines in the plasma of patients could be valuable in guiding immunotherapy policies. We assessed the plasma levels of 4 major cytokines [interferon (IFN)-β, interleukin-2 (IL-2), tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β)] collected from 19 patients with ductal breast cancer (BCa), before surgery (BS) and 5 days after surgery (AS). The ratio AS/BS was also calculated and correlated with histopathological variables and tumor-infiltrating lymphocyte (TIL) density. The IFN-β and TNF-α levels were significantly higher in BCa patients, BS and AS, than healthy controls (P < 0.02). High IL-2 levels BS were linked with node involvement (P = 0.02), and marginally with HER2 expression (P = 0.08), while high TNF-α levels were linked with high PgR expression (P = 0.02). Increasing IFN-β, IL-2, and TNF-α levels were noted AS, which was more evident in patients with larger tumors. The TGF-β levels were significantly lower in BCa patients (P < 0.007). Linear regression analysis showed a direct association of IFN-β levels AS (P = 0.02, r = 0.52) and of TNF-α AS/BS-ratio (P = 0.001, r = 0.72) with TIL-density. It is suggested that although effector immune response is evident in the majority of early stage BCa patients, removal of the primary tumor further unblocks such responses.

Keywords: IFN-β; IL-2; TGF-β; TNF-α; breast cancer; tumor-infiltrating lymphocytes.

MeSH terms

  • Breast Neoplasms* / surgery
  • Cytokines*
  • Female
  • Humans
  • Interleukin-2
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha

Substances

  • Cytokines
  • Interleukin-2
  • Tumor Necrosis Factor-alpha
  • Transforming Growth Factor beta